Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Neurobiology of Disease
|
November 29, 2008
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals
Shuxin Hu, Aynun N Begum, Mychica R Jones, et al.
Nature Neuroscience
|
January 18, 2006
Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease
Lixia Zhao, Qiu-Lan Ma, Frédéric Calon, et al.
Analytical Biochemistry
|
February 22, 2020
A sensitive LC-MS assay using derivatization with boron trifluoride to quantify curcuminoids in biological samples
Alexander J Yoon, Haiqiang Wu, Roy D Pan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 18, 2008
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease
Aynun N Begum, Mychica R Jones, Giselle P Lim, et al.
The New England Journal of Medicine
|
December 22, 2006
PET of brain amyloid and tau in mild cognitive impairment
Gary W Small, Vladimir Kepe, Linda M Ercoli, et al.
Alzheimer'S Research & Therapy
|
October 31, 2012
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
John M Ringman, Sally A Frautschy, Edmond Teng, et al.
The Lancet. Neurology
|
March 21, 2015
Neuroinflammation in Alzheimer's disease
Michael T Heneka, Monica J Carson, Joseph El Khoury, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Neurobiology of Disease
|
November 29, 2008
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals
Shuxin Hu, Aynun N Begum, Mychica R Jones, et al.
Nature Neuroscience
|
January 18, 2006
Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease
Lixia Zhao, Qiu-Lan Ma, Frédéric Calon, et al.
Analytical Biochemistry
|
February 22, 2020
A sensitive LC-MS assay using derivatization with boron trifluoride to quantify curcuminoids in biological samples
Alexander J Yoon, Haiqiang Wu, Roy D Pan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 18, 2008
Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease
Aynun N Begum, Mychica R Jones, Giselle P Lim, et al.
The New England Journal of Medicine
|
December 22, 2006
PET of brain amyloid and tau in mild cognitive impairment
Gary W Small, Vladimir Kepe, Linda M Ercoli, et al.
Alzheimer'S Research & Therapy
|
October 31, 2012
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
John M Ringman, Sally A Frautschy, Edmond Teng, et al.
The Lancet. Neurology
|
March 21, 2015
Neuroinflammation in Alzheimer's disease
Michael T Heneka, Monica J Carson, Joseph El Khoury, et al.
Page
of 5